Mario Balsa· @MarioBalsaMD · X·· 3 days agoScore70
Body · original
From podium to practice, in real time!
@OncoAlert #Podium2Screen brings the final LITESPARK-011 data straight from #ESMO26! And who better to unpack it than @DrDanielHeng ✨
The slide is one thing…but the expert context is the OncoAlert part 😉
27 views · 0 likes · 0 reposts · 0 replies
OncoAlert 🚨 #ESMO26 #Podium2Screen LITESPARK-011 final analysis in #RCC Our @OncoAlert founding faculty @DanielHengMD 🇨🇦 presents belzutifan + lenvatinib vs cabo after anti–PD-(L)1: ➡️ PFS HR 0.74 (14.8 vs 10.8 mo) ➡️ ORR 53% vs 40%, DOR 22.0 vs 11.9 mo ➡️ OS HR 0.85, not significant 👇 #KidneyCancer #GUOnc Pinging Our Faculty @DrChoueiri, @tompowles1, @apolo_andrea, @neerajaiims, @montypal, @Silke_Gillessen, @AOmlin, @brian_rini, @PGrivasMDPhD, @TiansterZhang, @amerseburger, @DrDanielHeng, @HHammersMD, @scocmem, @AndreaNecchi, @AmandaNizamMD, @drenriquegrande, @nataliagandur, @AlbigesL, @cdanicas, @declangmurphy, @seanmmcbride, @shilpaonc, @DrRanaMcKay, @scserendipity1, @DrYukselUrun, @ravikanesvaran, @BraunMDPhD, @EfstathiouEleni, @mzugman, @crisbergerot, @niklas_kluemper @Markuseckstein3在 X 查看被引用的帖子
Source: Mario Balsa · x.com